← Back to headlines
Johnson & Johnson (JNJ) Announces the FDA Approval of TECVAYLI® plus DARZALEX FASPRO®
10 Mar, 08:38 — 10 Mar, 08:38
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
11m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
4h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
4h ago
Study Reveals Hidden Arterial Calcification in Young Adults
5h ago